Quick Answer
Mosaic ImmunoEngineering Inc. reported Cash and Equivalents of $115.0 thousand for fiscal year 2024.
Mosaic ImmunoEngineering Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2024 | $115.0K | -26.4% |
| 2023 | $156.2K | -29.2% |
| 2022 | $220.6K | -2.4% |
| 2021 | $226.1K | -35.9% |
| 2020 | $352.7K | -38.3% |
| 2020 | $571.9K | -27.3% |
| 2019 | $787.1K | -65.7% |
| 2018 | $2.30M | +134.6% |
| 2017 | $979.6K | -15.5% |
| 2016 | $1.16M | -56.7% |
| 2015 | $2.68M | -43.2% |
| 2014 | $4.72M | -37.7% |
| 2013 | $7.57M | +61.2% |
| 2012 | $4.70M | -44.4% |
| 2011 | $8.45M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $31.8K | +453.7% | -40.7% |
| June 30, 2025 | $53.6K | +1335.0% | -37.6% |
| March 31, 2025 | $85.9K | +32.1% | -25.3% |
| December 31, 2024 | $115.0K | -26.4% | +1905.2% |
| September 30, 2024 | $5.7K | -97.7% | +53.6% |
| June 30, 2024 | $3.7K | -99.0% | -94.3% |
| March 31, 2024 | $65.0K | -48.3% | -58.4% |
| December 31, 2023 | $156.2K | -29.2% | -38.2% |
- Mosaic ImmunoEngineering Inc. showed a decrease of -26.4% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2011–2024 period, Mosaic ImmunoEngineering Inc.’s cash and equivalents has declined by 98.6% (from $8.45 million to $115.0 thousand).
- The most recent figure is from Mosaic ImmunoEngineering Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 15, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: